Our diagnostic imaging services are provided by the same Board-certified radiologists, skilled technologists and compassionate support staff you’ve come to expect from Miami Cancer Institute.
Miami Cancer Institute can provide access to clinical trials not widely available elsewhere. Clinical trials find new ways to treat and diagnose cancer and are ongoing. If an appropriate trial is available, we will talk to you about the benefits and risks.
At Miami Cancer Institute, we understand that the true definition of compassionate care is that nothing is more important than the patient sitting in front of you. We are ready to care for you.
As Florida's only member of the Memorial Sloan Kettering (MSK) Cancer Alliance, Miami Cancer Institute is part of a deep and functional collaboration that affords patients access to innovative treatments right here at home and ensures that the standards of care developed by our multidisciplinary disease management team match those at MSK.
Mark Kelly, M.D., is a board-certified urological oncologist at Baptist Health Miami Cancer Institute. He specializes in multidisciplinary prostate cancer care.
Dr. Kelly has devoted his career to managing prostate cancer in a highly individualized manner, empowering his patients with shared decision making. He uses advanced imaging, biomarkers and therapeutic interventions as well as active surveillance for people who do not need more aggressive treatment.
Dr. Kelly was one of the first urologists in Los Angeles to develop an active surveillance program. He was also an early adopter of focal therapy for men diagnosed with discrete, potentially lethal prostate cancer. Focal therapy uses advanced imaging and minimally invasive, ablative surgical techniques to remove cancer while leaving the rest of the organ intact.
Upholding the mission of Miami Cancer Institute and Baptist Health, Dr. Kelly enjoys partnering with his patients, looking at the whole person, their lifestyle and health practices and helping them understand that change is possible.